Furthermore, breast cancer patients showed that a reduction in the concentration of HMW adiponectin had an important effect on insulin resistance and metabolic syndrome, and this was associated with an increased risk of breast cancer mortality [47]. This evidence concerns the gene ADIPOQ and metabolic syndrome.